The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.

Diabetic Ketoacidosis Raises Risk of In-Hospital Mortality, Hospital Readmission in Heart Failure

May 17, 2022

Diabetic ketoacidosis increased the likelihood of in-hospital mortality by 61%, the likelihood of major adverse cardiovascular events by 56%, and a likelihood of 30-day readmission by 12% among patients hospitalized with heart failure in the US.

New Research Underlines the Importance of Early Interventions in Type 2 Diabetes

May 16, 2022

A University of Surrey-led study found patients achieving optimal glucose control in the first 12 months proceeding a T2D diagnosis had a lower risk of cardiovascular events than their counterparts who did not achieve optimal glucose control.

Tirzepatide (Mounjaro) Wins FDA Approval for Type 2 Diabetes

May 13, 2022

Announced on May 13, the approval indicates Eli Lilly and Company's novel dual GLP-1/GIP agonist, tirzepatide (Mounjaro), for use as an adjunct to diet and exercise to improve blood sugar in adult patients with type 2 diabetes.

Diabetes Dialogue: ATTD 2022 Recap

May 07, 2022

In this special edition ATTD Recap episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini provide insight from ATTD 2022, including the latest updates in the world of diabetes smartphone apps, smart insulin pens, and CGM systems.

Vegan Diets Can Improve HbA1c, Body Weight in Overweight or Type 2 Diabetes

May 06, 2022

Data from a study presented at the European Congress on Obesity details the effects of adherence to a vegan diet on cardiometabolic health using data obtained from randomized controlled trials assessing the effects of vegan diets as an intervention.

iLet Bionic Pancreas Shows Promise in Pivotal Trial

May 04, 2022

Data from a pivotal trial presented at ATTD 2022 demonstrate the use of the iLet Bionic Pancreas was associated with significant improvements in HbA1c and TIR among a diverse study population of adults and children with type 1 diabetes compared with standard care.